down arrow

Cyfuse Biomedical KK

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3311800001
JPY
610.00
-327 (-34.9%)

Mar 27

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
169.04
32.54
5.21
24.21
28.14
8.27
7.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
169.04
32.54
5.21
24.21
28.14
8.27
7.30
Raw Material Cost
90.08
31.03
13.27
10.48
26.90
18.40
15.24
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.34
3.51
2.61
2.81
2.56
2.46
2.42
Selling and Distribution Expenses
217.15
220.25
222.85
254.06
222.56
215.71
110.79
Other Expenses
-0.53
-0.35
-0.26
-0.28
-0.26
-0.25
9.79
Total Expenditure (Excl Depreciation)
307.23
251.28
236.12
264.55
249.46
234.11
226.31
Operating Profit (PBDIT) excl Other Income
-138.2
-218.70000000000002
-230.9
-240.3
-221.29999999999998
-225.79999999999998
-219
Other Income
17.50
-11.77
-5.36
80.79
16.47
11.97
-0.87
Operating Profit (PBDIT)
-111.12
-221.32
-227.28
-151.81
-195.54
-204.78
-210.83
Interest
5.34
3.51
2.61
2.81
2.56
2.46
2.42
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
78.96
1.51
-8.07
13.73
1.24
-10.13
-7.95
Depreciation
9.57
9.19
9.00
7.73
9.32
9.10
9.06
Profit Before Tax
-126.03
-234.03
-238.90
-162.35
-207.42
-216.33
-222.30
Tax
0.64
0.64
0.64
0.64
0.64
0.64
0.64
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-126.66
-234.66
-239.53
-162.99
-208.06
-216.97
-222.94
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-126.66
-234.66
-239.53
-162.99
-208.06
-216.97
-222.94
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-126.66
-234.66
-239.53
-162.99
-208.06
-216.97
-222.94
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,757.63
2,857.14
2,330.45
2,394.96
2,542.41
2,726.16
2,931.03
Earnings per share (EPS)
-12.09
-25.83
-28.96
-19.9
-25.56
-26.68
-27.76
Diluted Earnings per share
-12.09
-25.83
-28.96
-19.9
-25.56
-26.68
-27.76
Operating Profit Margin (Excl OI)
-81.75%
-672.22%
-4434.66%
-992.58%
-786.59%
-2731.89%
-3001.44%
Gross Profit Margin
-68.89%
-690.94%
-4415.08%
-638.6%
-704.06%
-2506.81%
-2922.32%
PAT Margin
-74.93%
-721.15%
-4600.15%
-673.15%
-739.44%
-2624.53%
-3055.17%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 501.42% vs -10.51% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 39.12% vs -281.14% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 39.34% vs -34.60% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 103.85% vs 8.33% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Cyfuse Biomedical KK With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
169.04
165.60
3.44
2.08%
Other Operating Income
0.00
0.00
0.00
Total Operating income
169.04
165.60
3.44
2.08%
Raw Material Cost
90.08
177.22
-87.14
-49.17%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.34
0.33
5.01
1,518.18%
Selling and Distribution Expenses
217.15
107.06
110.09
102.83%
Other Expenses
-0.53
9.98
-10.51
-105.31%
Total Expenditure (Excl Depreciation)
307.23
384.42
-77.19
-20.08%
Operating Profit (PBDIT) excl Other Income
-138.19
-218.82
80.63
36.85%
Other Income
17.50
-7.53
25.03
332.40%
Operating Profit (PBDIT)
-111.12
-226.34
115.22
50.91%
Interest
5.34
0.33
5.01
1,518.18%
Exceptional Items
0.00
-1.25
1.25
100.00%
Gross Profit (PBDT)
78.96
-11.62
90.58
779.52%
Depreciation
9.57
0.00
9.57
Profit Before Tax
-126.03
-227.92
101.89
44.70%
Tax
0.64
0.54
0.10
18.52%
Provisions and contingencies
0
0
0.00
Profit After Tax
-126.66
-228.46
101.80
44.56%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-126.66
-228.46
101.80
44.56%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-126.66
-228.46
101.80
44.56%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,757.63
2,138.82
618.81
28.93%
Earnings per share (EPS)
-12.09
-0.63
-11.46
-1,819.05%
Diluted Earnings per share
-12.09
-0.63
-11.46
-1,819.05%
Operating Profit Margin (Excl OI)
-81.75%
-132.13%
0.00
50.38%
Gross Profit Margin
-68.89%
-137.63%
0.00
68.74%
PAT Margin
-74.93%
-137.96%
0.00
63.03%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 16.90 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 420.00% vs 525.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 501.42% vs -10.51% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit -12.67 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 46.02% vs 2.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 39.12% vs -281.14% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -12.86 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 38.62% vs 5.59% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 39.34% vs -34.60% in Dec 2024

Quarterly - Interest
Interest 0.53 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 51.43% vs 34.62% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 103.85% vs 8.33% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -81.75%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."